Patients should be advised that "GLP-1 probiotic" marketing claims are not FDA-evaluated and may be misleading
Although these two drugs were originally developed to improve glycemic control in people with type 2 diabetes, they simultaneously cause significant weight loss in these patients, without too many major side effects, and could therefore represent a new therapeutic strategy for the normalization of body weight
However, eligibility depends on your overall health status, disease control (particularly diabetes stability), absence of active side effects, and individual donation center policies
At TrimRx, we believe that managing your health should feel empowering, not stressful
Down 25lbs, Eden's metabolic health approach is refreshing and effective
Pasquini L, Palhano-Fontes F, Araujo DB